Progenics, Somatix in phase III cancer vaccine trials.
Glaser
V
V
D000951:Antigens, Neoplasm / Q000235:genetics; D001709:Biotechnology; D019496:Cancer Vaccines / Q000494:pharmacology*; D017326:Clinical Trials, Phase III as Topic; D015195:Drug Design; D005818:Genetic Engineering; D006801:Humans; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines